Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|November 15, 1986
Effects of sustained intravenous diltiazem infusion in healthy personsK A Ellenbogen, S F Roark, M S Smith, et al.
Journal of the American College of Cardiology|April 1, 1995
Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardiaM E Hamer, W E Wilkinson, W K Clair, et al.
Circulation|February 1, 1982
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokineticsS C Hammill, D G Shand, P A Routledge, et al.
Pacing and Clinical Electrophysiology : PACE|May 1, 1994
Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptomsM E Hamer, W K Clair, W E Wilkinson, et al.
Journal of the American College of Cardiology|September 15, 2000
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) InvestigatorsE L Pritchett, R L Page, S J Connolly, et al.
The American Journal of Cardiology|November 13, 2001
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillationS J Connolly, D J Schnell, R L Page, et al.
The New England Journal of Medicine|November 15, 1979
Ventricular fibrillation in the Wolff-Parkinson-White syndromeG J Klein, T M Bashore, T D Sellers, et al.
Archives of Internal Medicine|November 1, 1986
Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardiaA L Sintetos, S F Roark, M S Smith, et al.
Circulation|November 1, 1978
Temporary, catheter-induced block in accessory pathwaysT L Novick, E L Pritchett, R W Campbell, et al.
Pageof 17